๐ฐ Cardiovascular Development News
Page 3 - Cardiovascular Development News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Cardiovascular Development. Real-time updates on events, politics, business and more.
April 26, 2023
If approved, CAMZYOS would be the first cardiac myosin inhibitor in Europe that specifically targets the source of obstructive HCM Recommendation based on positive Phase 3 EXPLORER-HCM and... | June 18, 2023
March 24, 2023
/PRNewswire/ -- The "Global Sparkling Wine Market Size, Segments, Outlook, and Revenue Forecast 2022-2028 by Type, Product, Distribution Channel, and Regions"...
December 1, 2022
The experimental study, led by researchers at the CNIC, shows that boosting the expression of this adrenalin receptor in heart cells improves mitochondrial function in the heartย ย
November 8, 2022
Non-compaction cardiomyopathy is a heart condition caused by defects that arise during fetal development and can have diverse health impacts in affected individuals, including sudden cardiac death.
July 22, 2022
Results of first vascular robotics study on this scale in China will be published in March 2023ย
June 28, 2022
Partnership will transform ASC cardiovascular care delivery and expand patient accessย
March 18, 2022
2021 July 13 โ Our study "In vivo dynamic 3D imaging of oocytes...
February 17, 2022
Positive results were announced from a phase 3 study evaluating mavacamten in adults with symptomatic obstructive HCM who are eligible for SRT.
December 23, 2021
Research led by the Centenary Institute and the Harvard Medical School, Boston, shows that a compound present in current beta blocker treatments could